骨转换生化指标的研究进展及选择依据

被引：11

作者：

彭应梅 ^{[1
]}

张雪竹 ^{[2
]}

于建春 ^{[2
]}

韩景献 ^{[2
]}

机构：

[1] 天津中医药大学

[2] 天津中医药大学第一附属医院针灸研究所

来源：

现代生物医学进展 | 2008年 / 03期

关键词：

骨代谢; 生化标志物; 血清; 尿;

D O I：

10.13241/j.cnki.pmb.2008.03.049

中图分类号：

R68 [骨科学（运动系疾病、矫形外科学）];

学科分类号：

1002 ; 100210 ;

摘要：

骨转化生化标志物的检测以其简便、快捷、无创等优点,在流行病学研究、长期跟踪监测、骨折风险评估等方面独具优势。与骨影像学和骨形态计量学观察相比,其反映的是骨细胞活性的实时信息,因此是评价骨转换状况、观察药物早期疗效的重要手段。

引用

页码：593 / 596

页数：4

共 24 条

[11]

Evaluation of bone disease in multiple myeloma:a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Alexandrakis MG,Passam FH,Malliaraki N,et al. Clinica Chimica Acta . 2002

[12]

Comparison of 10 serum bone turnover,markers in prostate carcinoma patients with metastatic spread:diagnostic,and prognostics implications. Jung K,Lein M,Stephan C,et al. International Journal of Cancer . 2004

[13]

Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-NTx are predictive for early progression of the bone disease during standard chemotherapy. Abildgaard N,Brixen K,Kristensen JE,et al. British Journal of Haematology . 2003

[14]

Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease(typeⅡautosomal dominant osteopetrosis). Alatalo SL,Ivaska KK,Waguespack SG,et al. Clinical Chemistry . 2004

[15]

Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Chao TY,Yu JC,Ku CH,et al. Clinical Cancer Research . 2005

[16]

Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells. Zhang JH,Wang J,Tang J,et al,,CHEN J. Anticancer Research . 2004

[17]

Soluble cathepsin K:a novel marker for the prediction of nontraumatic fractures?. Holzer G,Noske H,Lang T,et al. Journal of Laboratory and Clinical Medicine . 2005

[18]

The use of biochemical markers of bone turnover in osteoporosis.Committee of Scientific Advisors of the International Osteoporosis Foundation. Delmas PD,Eastell R,Garnero P,et al. Osteoporosis International . 2000

[19]

Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17

[20]

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy,or combination therapy:a three-year, double-blind,placebo-controlled,randomize. Greenspan SL,Resniek NM,Parker RA. Clinical Endocrinology . 2005

← 1 2 3 →